Current
1.6×
5-Year Average
1.4×
All-Time High
2.5×
All-Time Low
0.9×
P/S Ratio daily chart for Labcorp Holdings (LH)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for Labcorp Holdings (LH) from 2001 to 2025
| 2025 | $20.70B | $13.95B | 1.5× | +0.0× | |
| 2024 | $19.17B | $13.01B | 1.5× | -0.1× | |
| 2023 | $19.30B | $12.16B | 1.6× | +0.2× | |
| 2022 | $17.90B | $13.36B | 1.3× | -0.3× | |
| 2021 | $25.72B | $16.12B | 1.6× | +0.4× | |
| 2020 | $17.05B | $13.98B | 1.2× | -0.0× | |
| 2019 | $14.13B | $11.55B | 1.2× | +0.3× | |
| 2018 | $10.88B | $11.33B | 1.0× | -0.4× | |
| 2017 | $14.00B | $10.44B | 1.3× | +0.2× | |
| 2016 | $11.39B | $9.64B | 1.2× | -0.1× | |
| 2015 | $10.76B | $8.68B | 1.2× | -0.1× | |
| 2014 | $7.84B | $6.01B | 1.3× | +0.1× | |
| 2013 | $6.73B | $5.81B | 1.2× | -0.1× | |
| 2012 | $6.96B | $5.67B | 1.2× | -0.1× | |
| 2011 | $7.17B | $5.54B | 1.3× | -0.2× | |
| 2010 | $7.57B | $5.00B | 1.5× | +0.1× | |
| 2009 | $6.79B | $4.69B | 1.4× | +0.1× | |
| 2008 | $5.95B | $4.51B | 1.3× | -0.5× | |
| 2007 | $7.35B | $4.07B | 1.8× | -0.3× | |
| 2006 | $7.70B | $3.59B | 2.1× | +0.3× | |
| 2005 | $6.06B | $3.33B | 1.8× | -0.1× | |
| 2004 | $5.92B | $3.08B | 1.9× | +0.4× | |
| 2003 | $4.47B | $2.94B | 1.5× | +0.4× | |
| 2002 | $2.89B | $2.51B | 1.2× | -1.1× | |
| 2001 | $4.86B | $2.20B | 2.2× | — |
- 20251.5×
- 20241.5×
- 20231.6×
- 20221.3×
- 20211.6×
- 20201.2×
- 20191.2×
- 20181.0×
- 20171.3×
- 20161.2×
- 20151.2×
- 20141.3×
- 20131.2×
- 20121.2×
- 20111.3×
- 20101.5×
- 20091.4×
- 20081.3×
- 20071.8×
- 20062.1×
- 20051.8×
- 20041.9×
- 20031.5×
- 20021.2×
- 20012.2×
About P/S Ratio at Labcorp Holdings (LH)
Labcorp Holdings (LH) P/S ratio is 1.6× as of June 5, 2026. The 5-year average is 1.4×. The sector median currently stands at 3.5×. The current ratio is at the 74th percentile of its own 10-year history.
Labcorp Holdings (LH) historical P/S ratio has ranged from a low of 0.9× (2020) to a high of 2.5× (2002) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
Labcorp Holdings P/S Ratio by Year
Labcorp Holdings P/S Ratio 2025: 1.5×
Labcorp Holdings (LH) P/S ratio in 2025 was 1.5×, expanded from 1.5× the prior year.
Labcorp Holdings P/S Ratio 2024: 1.5×
Labcorp Holdings (LH) P/S ratio in 2024 was 1.5×, contracted from 1.6× the prior year.
Labcorp Holdings P/S Ratio 2023: 1.6×
Labcorp Holdings (LH) P/S ratio in 2023 was 1.6×, expanded from 1.3× the prior year.
Labcorp Holdings P/S Ratio 2022: 1.3×
Labcorp Holdings (LH) P/S ratio in 2022 was 1.3×, contracted from 1.6× the prior year.
Labcorp Holdings P/S Ratio 2021: 1.6×
Labcorp Holdings (LH) P/S ratio in 2021 was 1.6×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of Labcorp Holdings (LH), ranked by P/S ratio.
| 2.5× | |
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.5×
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
Labcorp Holdings (LH) Key Financials
Charts, filings, and peer comparison for every metric